Fundraising Fox
Bioscience Equity Partners
Venture capitalDubai · Late Stage · 1 people tracked
Find your way into Bioscience Equity Partners
Sign up to see every warm intro you have to Bioscience Equity Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bioscience Equity Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Bioscience Equity Partners structures, anchors, and closes institutional capital transactions across two divisions. In life sciences, its affiliated anchor fund Antisoma Venture Capital anchors roughly half of each round for biotechnology, medical technology, and digital health companies, with the remainder syndicated across a consortium of sovereign and quasi-sovereign funds. Its Infrastructure & Sovereign Advisory division structures and executes infrastructure-grade transactions for governments, ministries, sovereign funds, and state-owned enterprises across energy, agricultural biotechnology, and defence-adjacent manufacturing. The firm runs every mandate from origination to close and engages only counterparties known to its consortium, declining unsolicited approaches.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's website
George Syrmalis is CEO of Bioscience Equity Partners S.A. (BEP). In an interview with Medical Plastics News, he discussed how early-stage medical device companies in Europe and North America need to move beyond scientific strength toward institutional readiness to attract cross-border and sovereign capital, including from the Gulf and Asia.
Frequently asked questions
- What stage does Bioscience Equity Partners invest at?
- Bioscience Equity Partners invests at the Late Stage stage.
- What sectors does Bioscience Equity Partners focus on?
- Bioscience Equity Partners focuses on Advanced Manufacturing, AgTech, Biotech, Defense Tech, Digital Health, Energy, Healthtech, Longevity, Medical Devices.
- Where is Bioscience Equity Partners located?
- Bioscience Equity Partners is headquartered in Dubai, AE.
Media · Podcasts & interviews
featuring the teamInside the Mind of a Global Biotech Investor: Dr. George Syrmalis, CEO, Bioscience Equity Partners
Analyzing Healthcare by SCALE Community · George Syrmalis
Images
Similar investors
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Brookstreet Equity Partners LLP is a London-based, family-office-originated investment manager established by shipping and principal-capital families. It deploys hybrid growth capital focused on AI-driven innovations across digital transformation, energy transition, longevity, and dual-use defence technologies.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.